BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31608927)

  • 1. Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007-2016 from a national quality register.
    Jeremiasen M; Linder G; Hedberg J; Lundell L; Björ O; Lindblad M; Johansson J
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31608927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.
    van der Werf LR; Wijnhoven BPL; Fransen LFC; van Sandick JW; Nieuwenhuijzen GAP; Busweiler LAD; van Hillegersberg R; Wouters MWJM; Luyer MDP; van Berge Henegouwen MI
    Ann Surg; 2019 Nov; 270(5):868-876. PubMed ID: 31634182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.
    Kjaer DW; Nassar M; Jensen LS; Svendsen LB; Mortensen FV
    Dis Esophagus; 2017 Feb; 30(3):1-7. PubMed ID: 27001181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International benchmarking in oesophageal and gastric cancer surgery.
    Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
    BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma.
    Kauppila JH; Ringborg C; Johar A; Lagergren J; Lagergren P
    Gastric Cancer; 2018 May; 21(3):533-541. PubMed ID: 28852939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness in esophagogastric cancer.
    Knab LM; Belotte J; Munshi HG; Bentrem DJ
    Cancer Treat Res; 2015; 164():121-42. PubMed ID: 25677022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
    Wei S; Tian J; Song X; Chen Y
    Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Busweiler LA; Henneman D; Dikken JL; Fiocco M; van Berge Henegouwen MI; Wijnhoven BP; van Hillegersberg R; Rosman C; Wouters MW; van Sandick JW;
    Eur J Surg Oncol; 2017 Oct; 43(10):1962-1969. PubMed ID: 28797755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?
    Mazer LM; Poultsides GA
    Surg Clin North Am; 2019 Jun; 99(3):457-469. PubMed ID: 31047035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation.
    Merkow RP; Bilimoria KY; McCarter MD; Phillips JD; DeCamp MM; Sherman KL; Ko CY; Bentrem DJ
    Arch Surg; 2012 Nov; 147(11):1009-16. PubMed ID: 23165615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
    Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
    Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of surgical treatment of cancer of the stomach and gastro-esophageal junction in the Czech Republic.
    Duda M; Dušek L; Jínek T; Adamčík L; Škrovina M
    Rozhl Chir; 2018; 97(7):309-319. PubMed ID: 30442012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland.
    Kauppila JH; Ohtonen P; Karttunen TJ; Kokkola A; Laine S; Rantanen T; Ristimäki A; Räsänen JV; Saarnio J; Sihvo E; Toikkanen V; Tyrväinen T
    BMJ Open; 2019 Jan; 9(1):e024094. PubMed ID: 30782726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY; Curran WJ; El-Rayes BF; Behera M; Patel PR
    Cancer; 2020 Jan; 126(1):37-45. PubMed ID: 31532544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer.
    Weitz J; Jaques DP; Brennan M; Karpeh M
    Ann Surg Oncol; 2004 Jul; 11(7):682-9. PubMed ID: 15231523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical aspects and results of the transhiatal resection in adenocarcinomas of the gastroesophageal junction.
    Ulrich B; Zahedi A
    Dis Esophagus; 2001; 14(2):115-9. PubMed ID: 11553220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.